[TVTX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
04-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 11.77%
YoY- -71.82%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 56,993 55,868 53,496 54,167 48,487 57,249 68,217 -11.30%
PBT -86,253 -65,760 -69,511 -66,979 -75,919 -51,569 -35,596 80.50%
Tax 78 63 145 53 52 4 43 48.79%
NP -86,331 -65,823 -69,656 -67,032 -75,971 -51,573 -35,639 80.46%
Tax Rate - - - - - - - -
Total Cost 143,324 121,691 123,152 121,199 124,458 108,822 103,856 23.97%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -151.48 -117.82 -130.21 -123.75 -156.68 -90.09 -52.24 103.47%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -1.27 -1.03 -1.09 -1.05 -1.20 -0.84 -0.59 66.79%
EPS Diluted -1.27 -1.03 -1.09 -1.05 -1.20 -0.84 -0.59 66.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.